Skip to search formSkip to main contentSkip to account menu

MED 15

Known as: MED-15, MED15 
National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

ST 679

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2013
2013
Evaluation of intestinal absorption of amtolmetin guacyl in rats: breast cancer resistant protein as a primary barrier of oral bioavailability.
2003
2003
Impact on the bowel of amtolmetin guacyl, a new gastroprotective non-steroidal anti-inflammatory drug.
2000
2000
The mechanism of action of amtolmetin guacyl, a new gastroprotective nonsteroidal anti-inflammatory drug.
1995
1995
Studies on the gastric tolerability of the new non-steroidal anti-inflammatory drug amtolmetin guacyl.
Unexpectedly high levels of gastric tolerance to the new non-steroidal anti-inflammatory drug (NSAID) amtolmetin guacyl (CAS… 
1992
1992
Pharmacological properties and toxicology of MED-15, a prodrug of tolmetin.
In this study the pharmacological evaluation of MED-15, a non-acidic prodrug of tolmetin, is described. After oral administration… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)